Global Skin Cancer Diagnosis and Therapeutics Market Research and Forecast

Transcription

1 Report Information More information from: Global Skin Cancer Diagnosis and Therapeutics Market Research and Forecast Report / Search Code: WGR Publish Date: 4 January, 2018 Price 1-user PDF : $ Enterprise PDF : $ Description: The global skin cancer diagnosis market is anticipated to generate $XX million by Skin cancer is the uncontrolled development of anomalous skin cells. It happens when unrepaired DNA harm to skin cells (frequently caused by bright radiation from daylight or tanning beds) triggers transformations, or hereditary imperfections, that lead the skin cells to duplicate quickly and frame threatening tumors. According to the skin cancer foundation each year in the U.S. more than 5.4 million instances of nonmelanoma skin disease are dealt with in more than 3.3 million people. Every year, there are more new instances of skin cancer than the joint number of tumors of the breast, prostate, lung and colon. In the vicinity of 40 and 50 percent of Americans who live to age 65 will have either basal cell carcinoma or squamous cell carcinoma. Basal cell carcinoma (BCC) is the most widely recognized type of skin cancer. More than 4 million cases are analyzed in the U.S. each year. Squamous cell carcinoma is the second most prevalent type of skin cancer. More than 1 million cases occur in the U.S. each year. Actinic keratosis is the most widely recognized pre-cancer; it affects more than 58 million Americans. Around 90% of non-melanoma skin tumors are related to exposure to bright (UV) radiation from the sun. The yearly cost of treating skin malignancies in the U.S. is assessed at $8.1 billion: about $4.8 billion for non-melanoma skin growths and $3.3 billion for melanoma. The exposure of human skin with the UV rays is considered to be one of the major causes of skin cancer. There are several factors that are driving the market such as rising incidences of skin cancer, hereditary causes including genetic disorder, utilization of combined therapy. The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer. The skin cancer diagnosis and therapeutics market has been segmented as by type, by treatment, by diagnosis, by stages and by end user. On the basis type the market has been bifurcated as Actinic Keratoses (AK), based cell carcinoma (BCC), squamous cell carcinoma (SCC), Melanoma. According to the therapy the market has been bifurcated as chemotherapy, targeted therapy, immunotherapy, radiotherapy, freezing, scraping and others. Based on diagnosis the market has been bifurcated as CT-scan, X-rays, dermatoscopy, sentinel lymph node biopsy, blood test and others On the basis of end user, the market has been bifurcated as multispecialty hospitals, cancer research centers and clinics. Geographically, the worldwide skin cancer diagnosis and therapeutics showcase is divided into North America, Europe, Asia-Pacific, and the Rest of the World., Asia Pacific market is considered to be the fastest growing market globally. The rise in the number of cancer patients in the APAC region is considered to rise eventually enabling the skin cancer diagnosis and therapeutics market to grow. The North America and Europe are considered to be the dominating markets due to various factors such as high healthcare expenditure, development in the technology, support from government, rise in the key players and various other factors. The key players in the skin cancer diagnosis and therapeutics market Include Bristol Myers Squibb Co., Aqua Pharmaceuticals LLC, AstraZeneca, GlaxoSmithKline, and so on. MARKET SEGMENTATION: Global skin cancer diagnosis and therapeutics market is segmented on the basis of, type, by therapies, by diagnosis, by end user and regional outlook. Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapies Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Region The Report covers:

2 Comprehensive research methodology of global skin cancer diagnosis and therapeutics This report also includes detailed and extensive market overview with key analyst insights. Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. Analysis of regional regulations and other government policies impacting the global skin cancer diagnosis and therapeutics Insights about market determinants which are stimulating the global skin cancer diagnosis and therapeutics Detailed and extensive market segments with regional distribution of forecasted revenues. Extensive profiles and recent developments of market players. Contents: 1. REPORT SUMMARY 1.1. RESEARCH METHODS AND TOOLS 1.2. MARKET BREAKDOWN BY SEGMENTS BY GEOGRAPHY BY STAKEHOLDERS 2. MARKET OVERVIEW AND INSIGHTS 2.1. DEFINITION 2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS KEY FINDINGS RECOMMENDATION CONCLUSION 2.3. REGULATIONS UNITED STATES EUROPEAN UNION CHINA INDIA REST OF THE WORLD 2.4. PATENT ANALYSIS 3. MARKET DETERMINANT 3.1. MOTIVATORS RISING INCIDENCE OF SKIN CANCER RISING UTILIZATION OF COMBINE THERAPIES FOR SKIN CANCER TREATMENT GOVERNMENT INITIATIVES TO INCREASE AWARENESS AMONG PEOPLE HEREDITARY CAUSES OF SKIN CANCER INCREASING FUNDING ACTIVITIES FOR ADVANCING TECHNOLOGIES AND THERAPIES 3.2. RESTRAINTS HIGH COST OF ASSOCIATED WITH THERAPIES UNMET NEED & DIAGNOSIS IN UNDER DEVELOPED ECONOMIES 3.3. OPPORTUNITIES R&D ON TREATMENT THERAPIES EMERGING MARKET SUCH AS APAC REGION 4. MARKET SEGMENTATION 4.1. GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET, BY TYPE ACTINIC KERATOSES (AK) BASEL CELL CARCINOMA(BCC) SQUAMOUS CELL CARCINOMA(SCC) MELANOMA OTHERS 4.2. GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET, BY THERAPY SURGERY TREATMENT RADIOTHERAPY CHEMOTHERAPY TARGETED THERAPY IMMUNOTHERAPY FREEZING SCRAPING LASER THERAPY 4.3. GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET, BY DIAGNOSIS DERMATOSCOPY SENTIEL LYMPNODE BIOPSY BLOOD TEST X-RAYS CT SCAN OTHERS

3 4.4. GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET, BY END USER MULTISPECIALITY HOSPITALS CANCER RESEARCH CENTERS CLINICS 5. COMPETITIVE LANDSCAPE 5.1. STRATEGY ANALYSIS 5.2. KEY COMPANY ANALYSIS 6. REGIONAL ANALYSIS 6.1. NORTH AMERICA UNITED STATES CANADA 6.2. EUROPE UNITED KINGDOM FRANCE GERMANY ITALY SPAIN REST OF EUROPE 6.3. ASIA PACIFIC INDIA CHINA JAPAN 6.4. REST OF THE WORLD 7. COMPANY PROFILES 7.1. AGILENT TECHNOLOGIES 7.2. AMGEN, INC AQUA PHARMACEUTICALS LLC 7.4. ASTRAZENECA 7.5. BRISTOL MYERS SQUIBB CO DAIICHI SANKYO COMPANY, LIMITED 7.7. ELEKTA AB 7.8. ELI LILLY AND CO F. HOFFMANN-LA ROCHE LTD GLAXOSMITHKLINE ICAD INC MEDA AB MERCK & CO. INC NOVARTIS INTERNATIONAL AG PFIZER QIAGEN N.V. COMPANY SANOFI TEVA PHARMACEUTICALS VALEANT PHARMACEUTICALS INC VARIAN MEDICAL SYSTEMS INC. TABLE # 1 GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY GEOGRAPHY, , TABLE # 2 GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY TYPE ($ TABLE # 3 GLOBAL ACTINIC KERATOSES(AK) MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 4 GLOBAL BASED CELL CARCINOMA(BCC) MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 5 GLOBAL SQUAMOUS CELL CARCINOMA(SCC) MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 6 GLOBAL SARCOMAS MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 7 GLOBAL MELANOMA MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 8 GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY THERAPY ($ TABLE # 9 GLOBAL SURGERY TREATMENT MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 10 GLOBAL RADIOTHERAPY MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 11 GLOBAL CHEMOTHERAPY MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 12 GLOBAL TARGETED THERAPY MARKET RESEARCH AND ANALYSIS, , ($

4 TABLE # 13 GLOBAL IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 14 GLOBAL FREEZING MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 15 GLOBAL SCRAPING MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 16 GLOBAL TARGETED THERAPY MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 17 GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS, , ($ TABLE # 18 GLOBAL DERMATOSCOPY MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 19 GLOBAL SENTINEL LYMPH NODE BIOPSY MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 20 GLOBAL BLOOD TEST MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 21 GLOBAL X-RAYS MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 22 GLOBAL CT-SCAN MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 23 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 24 GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY END USER , ($ TABLE # 25 GLOBAL MULTISPECIALTY HOSPITALS MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 26 GLOBAL CANCER RESEARCH INSTITUTE MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 27 GLOBAL CLINICS MARKET RESEARCH AND ANALYSIS, , ($ TABLE # 28 MERGER AND ACQUISITION TABLE # 29 GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET, BY GEOGRAPHY ($ TABLE # 30 NORTH AMERICA SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY TYPE TABLE # 31 NORTH AMERICA SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY THERAPY TABLE # 32 NORTH AMERICA SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS TABLE # 33 NORTH AMERICA SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY END USER TABLE # 34 NORTH AMERICA SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY COUNTRIES TABLE # 35 EUROPE SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY TYPE TABLE # 36 EUROPE SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY THERAPY TABLE # 37 EUROPE SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS TABLE # 38 EUROPE SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY END USER TABLE # 39 EUROPE SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY COUNTRIES TABLE # 40 ASIA PACIFIC SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY TYPE TABLE # 41 ASIA PACIFIC SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY THERAPY TABLE # 42 ASIA PACIFIC SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS TABLE # 43 ASIA PACIFIC SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY END USER TABLE # 44 ASIA PACIFIC SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY COUNTRIES TABLE # 45 REST OF THE WORLD SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY TYPE TABLE # 46 REST OF THE SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY THERAPY TABLE # 47 REST OF THE WORLD SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS TABLE # 48 REST OF THE WORLD SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY END USER FIGURE # 1 GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SHARE, BY

5 TYPE , (IN %) FIGURE # 2 GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SHARE, BY THERAPY , (IN %) FIGURE # 3 GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SHARE, BY DIAGNOSIS , (IN %) FIGURE # 4 GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SHARE, BY END USER , (IN %) FIGURE # 5 GLOBAL SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SHARE, BY GEOGRAPHY , (IN %) FIGURE # 6 NORTH AMERICA SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, FIGURE # 7 US MARKET SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, FIGURE # 8 CANADA SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, FIGURE # 9 EUROPEAN SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, FIGURE # 10 UK SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, FIGURE # 11 FRANCE SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, FIGURE # 12 GERMANY SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, FIGURE # 13 ITALY SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, FIGURE # 14 SPAIN SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, FIGURE # 15 ROE SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, FIGURE # 16 ASIA SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, FIGURE # 17 INDIA SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, FIGURE # 18 CHINA SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, FIGURE # 19 JAPAN SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, FIGURE # 20 ROAPAC SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, FIGURE # 21 REST OF THE WORLD SKIN CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, wiseguyreports.com / Phone (US) (UK)